文献速递艾滋病与性传播感染

初诊时即启动抗逆转录病毒治疗在未治疗HIV感染成人中的效果

Initiation of antiretroviral therapy in treatment-naive adults with HIV infection at the first specialist appointment.
PubMed 文献 · J Antimicrob Chemother · 2022-01-01

该回顾性观察研究纳入108例新诊断HIV感染成人,在首次感染科专科就诊时即启动抗逆转录病毒治疗(ART)且未等待基线实验室结果。48周时ITT分析有效率为85.2%(92/108),治疗相关停药等于失败分析为91.7%(99/108),除9例外均实现病毒载量检测不到(<50拷贝/mL),未见与该策略相关的严重不良事件,HIV关怀保留率为93.5%(101/108)。

要点

  • 首次专科就诊时即启动ART且不等待基线实验室数据,48周病毒学有效率为85.2%(ITT分析,92/108)。
  • 治疗相关停药等于失败分析有效率为91.7%(99/108),除9例外病毒载量均<50拷贝/mL。
  • 48周HIV关怀保留率为93.5%(101/108),未见与该策略相关的严重不良事件。

核心结论

  • 在首次可及机会且无基线实验室数据时启动ART不降低疗效或安全性,可实现快速病毒学控制并达到较高的HIV关怀保留率。

研究设计与样本

  • 观察性回顾性研究,在马德里市中心一家三级医院评估首次专科就诊时且无基线实验室数据情况下开具ART的疗效与安全性。
  • 纳入新诊断HIV感染并在首次感染科专科就诊时、收到基线实验室结果前启动治疗的个体,不论选择何种ART方案。
  • 共纳入108名参与者。

主要发现

  • 多数参与者(99.1%)为男男性行为者(MSM),通过性交获得感染。
  • 启动时无基线实验室结果的ART疗效在ITT分析中为85.2%(92/108),在治疗相关停药等于失败分析中为91.7%(99/108)。
  • 除9名患者外,所有患者在启动ART后48周时病毒载量检测不到(<50拷贝/mL)。
  • 未观察到与该策略相关的严重不良效应。
  • 48周时101名参与者继续接受关怀,HIV关怀保留率为93.5%(101/108)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fast initiation of ART has been associated with higher rates of retention in HIV care and viral suppression at 48 weeks and with lower mortality rates. However, scarce evidence exists in our setting, where diagnosis and treatment are carried out in different contexts. METHODS: An observational retrospective study evaluating efficacy and safety of ART prescribed at the first specialist appointment, without baseline laboratory data, in a tertiary hospital in downtown Madrid. Individuals with a new diagnosis of HIV infection who initiated treatment at their first appointment with an infectious diseases specialist before receiving baseline laboratory results were included, irrespective of the ART regimen chosen. RESULTS: One hundred and eight participants were included. The majority (99.1%) were MSM who had acquired infection during sexual intercourse. The efficacy of ART, without baseline laboratory results at the time of initiation, was 85.2% (92/108) in the ITT analysis and 91.7% (99/108) in the treatment-related discontinuation equals failure analysis. All but nine patients presented an undetectable viral load (<50 copies/mL) at 48 weeks from starting ART. No serious adverse effects associated with the strategy were observed. In total, 101 participants continued care at 48 weeks with retention in HIV care rate of 93.5% (101/108). CONCLUSIONS: Initiating ART at the first available opportunity without baseline laboratory data does not reduce efficacy or safety of ART and achieves rapid virological control with high rates of retention in HIV care.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Al-Hayani AWM, Cabello-Úbeda A, Del Palacio-Tamarit M, et al. Initiation of antiretroviral therapy in treatment-naive adults with HIV infection at the first specialist appointment. J Antimicrob Chemother. 2022. PMID: 35289854. doi:10.1093/jac/dkac079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。